Statistics that quantify a person’s predisposition to diseases such as diabetes and cancer can be reverse-engineered to reveal the underlying genetic data, prompting privacy concerns ...

Experts say genetic testing for early-onset dementia is becoming increasingly common in IVF and the standard offer of genetic counselling for people with the condition has allowed more family members ...

A person’s genes play a far greater role in likely lifespan than previously thought, according to a major new study published Thursday in the journal Science. Using data from human twin studies, an ...

Mendel’s monastery garden experiments went largely unnoticed during his life, but their implications would ripple through science decades later. Gregor Mendel, Austrian botanist and founder of ...

Researchers have uncovered shared genetic pathways that link multiple psychiatric disorders. These new findings have the potential to change the way psychiatric disorders are diagnosed and treated, ...

RICHMOND, Va. (WRIC) — A new study from Virginia Commonwealth University (VCU) shows 14 psychiatric disorders share genetic roots, which can explain why some people have multiple diagnoses. The study, ...

Distinct psychiatric disorders have more in common biologically than previously believed, according to the largest and most detailed analysis to date of how genes influence mental illness. The study, ...

An international collective of researchers is delivering new insights into why having multiple psychiatric disorders is the norm rather than the exception. In a study published today in the journal ...

People who learn they have autism after age 6 — the current median age at diagnosis — are often described as having a “milder” form of autism than people diagnosed as toddlers. A new study challenges ...

Scientists from Mass General Brigham and the Broad Institute of MIT and Harvard have used CRISPR screens to identify genetic modifications that influence T cell function and survival in cultures and ...

Researchers have identified a genetic biomarker that predicts whether people with relapsing forms of multiple sclerosis (MS) will respond to glatiramer acetate (sold as Copaxone, among others) therapy ...

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people's genetic risk of developing the ...